Volume 239, Issue 5 | Psychopharmacology

Search all Psychopharmacology articles

Volume 239, Issue 5

May 2022

Special Issue on Cannabis and Cannabinoids

Issue Editors:

Deepak Cyril D'Souza,
H Valerie Curran

36 articles in this issue

Editorial
Deepak Cyril D’Souza
Helen Valerie Curran
Editorial 22 March 2022 Pages: 1143 - 1145
Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21
C. Sakal
M. Lynskey
D. J. Nutt
Theoretical and Methodological Perspective 10 May 2021 Pages: 1147 - 1155
Cannabinoids, reward processing, and psychosis
Brandon Gunasekera
Kelly Diederen
Sagnik Bhattacharyya
Review Open access 01 March 2021 Pages: 1157 - 1177
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Edward Chesney
Dominic Oliver
Philip McGuire
Review Open access 13 July 2021 Pages: 1179 - 1190
Is resting-state functional connectivity altered in regular cannabis users? A systematic review of the literature
Hannah Thomson
Izelle Labuschagne
Valentina Lorenzetti
Review 20 August 2021 Pages: 1191 - 1209
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies
Dimitri Daldegan-Bueno
Lucas O. Maia
Benedikt Fischer
Review Open access 06 October 2021 Pages: 1211 - 1230
Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence
Lauren Kuhns
Emese Kroon
Janna Cousijn
Review 06 November 2021 Pages: 1231 - 1249
Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis
Eef L. Theunissen
Johannes T. Reckweg
Johannes G. Ramaekers
Original Investigation Open access 26 January 2021 Pages: 1251 - 1261
Combined effect of alcohol and cannabis on simulated driving
Andrew Fares
Christine M. Wickens
Bruna Brands
Original Investigation 05 February 2021 Pages: 1263 - 1277
Sensory gating in tobacco-naïve cannabis users is unaffected by acute nicotine administration
Ashley M. Francis
Andrea Parks
Derek J. Fisher
Original Investigation 01 May 2021 Pages: 1279 - 1288
Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ⁹-THC)
Angela N. Henderson-Redmond
Diana E. Sepulveda
Daniel J. Morgan
Original Investigation 24 June 2021 Pages: 1289 - 1309
Endocannabinoid signaling of homeostatic status modulates functional connectivity in reward and salience networks
Cristina Martín-Pérez
Oren Contreras-Rodríguez
Antonio Verdejo-García
Original Investigation 02 July 2021 Pages: 1311 - 1319
Effects of combined THC and heroin vapor inhalation in rats
Arnold Gutierrez
Jacques D. Nguyen
Michael A. Taffe
Original Investigation 23 June 2021 Pages: 1321 - 1335
Cannabinoid receptor type 1 antagonists alter aspects of risk/reward decision making independent of toluene-mediated effects
Kevin M. Braunscheidel
Michael P. Okas
John J. Woodward
Original Investigation 22 July 2021 Pages: 1337 - 1347
Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis
Sam Craft
Jason A. Ferris
Tom P. Freeman
Original Investigation Open access 17 September 2021 Pages: 1349 - 1357
Chronic ∆-9-tetrahydrocannabinol administration delays acquisition of schedule-induced drinking in rats and retains long-lasting effects
Esmeralda Fuentes-Verdugo
Gabriela E. López-Tolsa
Miguel Miguéns
Original Investigation Open access 26 August 2021 Pages: 1359 - 1372
Context dependent differences in working memory related brain activity in heavy cannabis users
Emese Kroon
Lauren Kuhns
Janna Cousijn
Original Investigation Open access 27 August 2021 Pages: 1373 - 1385
Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers
Steven J. Nieto
Alexandra Venegas
Lara A. Ray
Original Investigation Open access 15 October 2021 Pages: 1387 - 1395
Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations
Catherine F. Moore
Elise M. Weerts
Original Investigation 15 October 2021 Pages: 1397 - 1408
Acute effects of Δ⁹-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity
Lisa-Marie Greenwood
Samantha J. Broyd
Nadia Solowij
Original Investigation 01 November 2021 Pages: 1409 - 1424
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey
Joanna Kuc
Hannes Kettner
Robin L. Carhart-Harris
Original Investigation Open access 04 November 2021 Pages: 1425 - 1440
How do cannabis users mentally travel in time? Evidence from an fMRI study of episodic future thinking
Parnian Rafei
Tara Rezapour
Javad Hatami
Original Investigation 25 October 2021 Pages: 1441 - 1457
Comparative effects of cannabinoid CB1 receptor agonist and antagonist on timing impulsivity induced by d-amphetamine in a differential reinforcement of low-rate response task in male rats
Shuo-Fu Chen
Wei-Chung Hsu
Ruey-Ming Liao
Original Investigation 06 November 2021 Pages: 1459 - 1473
Evaluation of the terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement
Joshua A. Bilbrey
Yuma T. Ortiz
Jenny L. Wilkerson
Original Investigation 30 November 2021 Pages: 1475 - 1486
Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women
Margaret C. Wardle
Elisa Pabon
Harriet de Wit
Original Investigation 01 February 2022 Pages: 1487 - 1497
Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
Lívia Maria Bolsoni
José Alexandre S. Crippa
Antonio Waldo Zuardi
Original Investigation 14 January 2022 Pages: 1499 - 1507
Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada
Janni Leung
Gary Chan
David Hammond
Original Investigation Open access 12 January 2022 Pages: 1509 - 1519
Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway
Baoyu Shen
Dongxian Zhang
Lihua Li
Original Investigation 08 January 2022 Pages: 1521 - 1537
The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study
Michael A. P. Bloomfield
Yumeya Yamamori
Tom P. Freeman
Original Investigation Open access 21 April 2022 Pages: 1539 - 1549
Effects of regular cannabis and nicotine use on acute stress responses: chronic nicotine, but not cannabis use, is associated with blunted adrenocortical and cardiovascular responses to stress
Mustafa al’Absi
Briana DeAngelis
Sharon Allen
Original Investigation 11 March 2022 Pages: 1551 - 1561
Adolescent THC exposure: effects on pain-related, exploratory, and consummatory behaviors in adult male vs. female rats
Hannah Y. Gogulski
Rebecca M. Craft
Original Investigation 10 March 2022 Pages: 1563 - 1578
The effects of prenatal nicotine and THC E-cigarette exposure on motor development in rats
S. Hussain
K.R Breit
J.D Thomas
Original Investigation 26 March 2022 Pages: 1579 - 1591
Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses
Laísa S. Umpierrez
Priscila A. Costa
Jennifer L. Cornish
Original Investigation Open access 18 April 2022 Pages: 1593 - 1603
Comparison between cannabidiol and sertraline for the modulation of post-traumatic stress disorder-like behaviors and fear memory in mice
Xiao Han
Xiankui Song
Jin Li
Original Investigation 09 April 2022 Pages: 1605 - 1620
Sex differences in the acute effects of intravenous (IV) delta-9 tetrahydrocannabinol (THC)
Anahita Bassir Nia
Maria J. Orejarena
Mohini Ranganathan
Original Investigation 19 April 2022 Pages: 1621 - 1628
The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls
W. Lawn
N. Fernandez-Vinson
H. V. Curran
Original Investigation Open access 29 April 2022 Pages: 1629 - 1641